Answers are grounded in this paper and cite their sources.
Purpose Rapid molecular assays have increased microbiological confirmation of tuberculosis (TB), but the clinical meaning of discordant molecular and culture results remains incompletely defined. We compared the clinical phenotypes of patients with molecular-only, culture-only, and dual microbiological confirmation in pulmonary and extrapulmonary TB. Methods A multicenter observational cohort study was conducted in 22 Italian centres from 1 January 2021 to 30 May 2026. Patients with pulmonary TB (pTB) or pure extrapulmonary TB (epTB) and with both molecular and culture results were eligible. Patients were categorized accordingly to testing results as molecular-only (molecular positive/culture negative), culture-only (molecular negative/culture positive), or dual-confirmed (both positive). Logistic regression models estimated odds ratios (ORs) and adjusted odds ratios (aORs) for molecular-only and culture-only confirmation compared with dual-confirmed disease. Results 861 patients were included, of whom 685 with pTB (79.6%) and 176 with pure epTB (20.4%). In pTB, 83/685 (12.1%) were molecular-only, 76/685 (11.1%) culture-only, and 526/685 (76.8%) dual-confirmed, while in pure epTB, cases were respectively 29/176 (16.5%), 28/176 (15.9%), and 119/176 (67.6%). In pTB, molecular-only confirmation was independently associated with migrant status (aOR 24.24, 95% CI 2.97-197.66; p = 0.003) reflecting the marked predominance of migrants among molecular-only cases (82/83, 98.8%), diabetes (aOR 6.87, 95% CI 3.00-15.74; p < 0.001), and chronic pulmonary disease (aOR 3.62, 95% CI 1.30-10.12; p = 0.014). Culture-only pTB was associated with older age (aOR per 10 years 1.37, 95% CI 1.11–1.69; p = 0.003), female sex (aOR 2.28, 95% CI 1.08–4.82; p = 0.031), and respiratory failure (aOR 2.66, 95% CI 1.25–5.65; p = 0.011). In pure epTB, molecular-only confirmation was inversely associated with smear positivity (aOR 0.14, 95% CI 0.04–0.46; p = 0.001). Culture-only epTB was associated with lower odds of systemic symptoms (aOR 0.08, 95% CI 0.02–0.35; p < 0.001), longer total diagnostic delay (aOR per 30 days 1.06, 95% CI 1.02–1.11; p = 0.008), and lower odds of multiple extrapulmonary sites (aOR 0.31, 95% CI 0.10–0.99; p = 0.048). Conclusions Molecular and culture results identify overlapping but non-identical microbiological phenotypes. Molecular-only TB should not be interpreted as weak evidence of disease, while culture-only TB underlines the persistent role of culture in diagnostic pathways and resistance profiling.
No takes yet. Share an insight, caveat, or question.
Cotugno et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: